{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:35:12Z","timestamp":1794897312185,"version":"4.9.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"8075","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2025,8,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Signals from the microenvironment are known to be critical for development, stem cell self-renewal and oncogenic progression. Although some niche-driven signals that promote cancer progression have been identified<jats:sup>1\u20135<\/jats:sup>, concerted efforts to map disease-relevant microenvironmental ligands of cancer stem cell receptors have been lacking. Here, we use temporal single-cell RNA-sequencing (scRNA-seq) to identify molecular cues from the bone marrow stromal niche that engage leukaemia stem-enriched cells (LSCs) during oncogenic progression. We integrate these data with our human LSC RNA-seq and in vivo CRISPR screen of LSC dependencies<jats:sup>6<\/jats:sup> to identify LSC\u2013niche interactions that are essential for leukaemogenesis. These analyses identify the taurine\u2013taurine transporter (TAUT) axis as a critical dependency of aggressive myeloid leukaemias. We find that cysteine dioxygenase type 1 (CDO1)-driven taurine biosynthesis is restricted to osteolineage cells, and increases during myeloid disease progression. Blocking CDO1 expression in osteolineage cells impairs LSC growth and improves survival outcomes. Using TAUT genetic loss-of-function mouse models and patient-derived acute myeloid leukaemia (AML) cells, we show that TAUT inhibition significantly impairs in vivo myeloid leukaemia progression. Consistent with elevated TAUT expression in venetoclax-resistant AML, TAUT inhibition synergizes with venetoclax to block the growth of primary human AML cells. Mechanistically, our multiomic approaches indicate that the loss of taurine uptake inhibits RAG-GTP dependent mTOR activation and downstream glycolysis. Collectively, our work establishes the temporal landscape of stromal signals during leukaemia progression and identifies taurine as a key regulator of myeloid malignancies.<\/jats:p>","DOI":"10.1038\/s41586-025-09018-7","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:02:09Z","timestamp":1747220529000},"page":"263-272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Taurine from tumour niche drives glycolysis to promote leukaemogenesis"],"prefix":"10.1038","volume":"644","author":[{"given":"Sonali","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Rodems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3792-4317","authenticated-orcid":false,"given":"Cameron D.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Kaszuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo I.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1161-7957","authenticated-orcid":false,"given":"Kyle","family":"Swovick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Welle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Rock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2818-2526","authenticated-orcid":false,"given":"Francisco A.","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Ghaemmaghami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6969-239X","authenticated-orcid":false,"given":"Laura M.","family":"Calvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0351-9284","authenticated-orcid":false,"given":"Archan","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5584-584X","authenticated-orcid":false,"given":"W. Richard","family":"Burack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane L.","family":"Liesveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8639-8413","authenticated-orcid":false,"given":"Paul S.","family":"Brookes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5379-9440","authenticated-orcid":false,"given":"Joshua C.","family":"Munger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0869-3465","authenticated-orcid":false,"given":"Craig T.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9875-5994","authenticated-orcid":false,"given":"John M.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-6056","authenticated-orcid":false,"given":"Jeevisha","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"9018_CR1","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ccell.2016.10.003","volume":"30","author":"J Bajaj","year":"2016","unstructured":"Bajaj, J. et al. CD98-mediated adhesive signaling enables the establishment and propagation of acute myelogenous leukemia. Cancer Cell 30, 792\u2013805 (2016).","journal-title":"Cancer Cell"},{"key":"9018_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nature17392","volume":"532","author":"A Kaur","year":"2016","unstructured":"Kaur, A. et al. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature 532, 250\u2013254 (2016).","journal-title":"Nature"},{"key":"9018_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.stem.2015.06.006","volume":"17","author":"HY Kwon","year":"2015","unstructured":"Kwon, H. Y. et al. Tetraspanin 3 is required for the development and propagation of acute myelogenous leukemia. Cell Stem Cell 17, 152\u2013164 (2015).","journal-title":"Cell Stem Cell"},{"key":"9018_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell 121, 335\u2013348 (2005).","journal-title":"Cell"},{"key":"9018_CR5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/ncb2048","volume":"12","author":"L Vermeulen","year":"2010","unstructured":"Vermeulen, L. et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 12, 468\u2013476 (2010).","journal-title":"Nat. Cell Biol."},{"key":"9018_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s43018-020-0054-2","volume":"1","author":"J Bajaj","year":"2020","unstructured":"Bajaj, J. et al. An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia. Nat. Cancer 1, 410\u2013422 (2020).","journal-title":"Nat. Cancer"},{"key":"9018_CR7","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm.2890","volume":"18","author":"Y Sun","year":"2012","unstructured":"Sun, Y. et al. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat. Med. 18, 1359\u20131368 (2012).","journal-title":"Nat. Med."},{"key":"9018_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/35094059","volume":"1","author":"MJ Bissell","year":"2001","unstructured":"Bissell, M. J. & Radisky, D. Putting tumours in context. Nat. Rev. Cancer 1, 46\u201354 (2001).","journal-title":"Nat. Rev. Cancer"},{"key":"9018_CR9","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201911053","volume":"219","author":"J Bajaj","year":"2020","unstructured":"Bajaj, J., Diaz, E. & Reya, T. Stem cells in cancer initiation and progression. J. Cell Biol. 219, e201911053 (2020).","journal-title":"J. Cell Biol."},{"key":"9018_CR10","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1158\/2159-8290.CD-20-1680","volume":"11","author":"P Sharma","year":"2021","unstructured":"Sharma, P. et al. The next decade of immune checkpoint therapy. Cancer Discov. 11, 838\u2013857 (2021).","journal-title":"Cancer Discov."},{"key":"9018_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41, 374\u2013403 (2023).","journal-title":"Cancer Cell"},{"key":"9018_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ccell.2023.01.010","volume":"41","author":"O Elhanani","year":"2023","unstructured":"Elhanani, O., Ben-Uri, R. & Keren, L. Spatial profiling technologies illuminate the tumor microenvironment. Cancer Cell 41, 404\u2013420 (2023).","journal-title":"Cancer Cell"},{"key":"9018_CR13","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.cell.2019.04.040","volume":"177","author":"N Baryawno","year":"2019","unstructured":"Baryawno, N. et al. A cellular taxonomy of the bone marrow stroma in homeostasis and leukemia. Cell 177, 1915\u20131932 (2019).","journal-title":"Cell"},{"key":"9018_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41586-019-1104-8","volume":"569","author":"AN Tikhonova","year":"2019","unstructured":"Tikhonova, A. N. et al. The bone marrow microenvironment at single-cell resolution. Nature 569, 222\u2013228 (2019).","journal-title":"Nature"},{"key":"9018_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41556-019-0439-6","volume":"22","author":"C Baccin","year":"2020","unstructured":"Baccin, C. et al. Combined single-cell and spatial transcriptomics reveal the molecular, cellular and spatial bone marrow niche organization. Nat. Cell Biol. 22, 38\u201348 (2020).","journal-title":"Nat. Cell Biol."},{"key":"9018_CR16","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41375-019-0622-6","volume":"34","author":"H Kamijo","year":"2020","unstructured":"Kamijo, H. et al. Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47. Leukemia 34, 845\u2013856 (2020).","journal-title":"Leukemia"},{"key":"9018_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.4103\/0973-1482.151933","volume":"11","author":"M Islambulchilar","year":"2015","unstructured":"Islambulchilar, M., Asvadi, I., Sanaat, Z., Esfahani, A. & Sattari, M. Effect of taurine on attenuating chemotherapy-induced adverse effects in acute lymphoblastic leukemia. J. Cancer Res. Ther. 11, 426\u2013432 (2015).","journal-title":"J. Cancer Res. Ther."},{"key":"9018_CR18","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.cell.2024.03.011","volume":"187","author":"T Cao","year":"2024","unstructured":"Cao, T. et al. Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8+ T cells. Cell 187, 2288\u20132304 (2024).","journal-title":"Cell"},{"key":"9018_CR19","doi-asserted-by":"publisher","first-page":"e0121314","DOI":"10.1371\/journal.pone.0121314","volume":"10","author":"D Bausch-Fluck","year":"2015","unstructured":"Bausch-Fluck, D. et al. A mass spectrometric-derived cell surface protein atlas. PLoS ONE 10, e0121314 (2015).","journal-title":"PLoS ONE"},{"key":"9018_CR20","first-page":"27","volume":"4","author":"A Lasry","year":"2023","unstructured":"Lasry, A. et al. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nat. Cancer 4, 27\u201342 (2023).","journal-title":"Nat. Cancer"},{"key":"9018_CR21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1411543","volume":"258","author":"SH Zhang","year":"1992","unstructured":"Zhang, S. H., Reddick, R. L., Piedrahita, J. A. & Maeda, N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468\u2013471 (1992).","journal-title":"Science"},{"key":"9018_CR22","doi-asserted-by":"publisher","first-page":"12145","DOI":"10.1073\/pnas.89.24.12145","volume":"89","author":"QR Liu","year":"1992","unstructured":"Liu, Q. R., L\u00f3pez-Corcuera, B., Nelson, H., Mandiyan, S. & Nelson, N. Cloning and expression of a cDNA encoding the transporter of taurine and beta-alanine in mouse brain. Proc. Natl Acad. Sci. USA 89, 12145\u201312149 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9018_CR23","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1016\/j.cell.2024.04.013","volume":"187","author":"S Bandyopadhyay","year":"2024","unstructured":"Bandyopadhyay, S. et al. Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging. Cell 187, 3120\u20133140 (2024).","journal-title":"Cell"},{"key":"9018_CR24","doi-asserted-by":"publisher","first-page":"E1292","DOI":"10.1152\/ajpendo.00589.2011","volume":"302","author":"I Ueki","year":"2012","unstructured":"Ueki, I., Roman, H. B., Hirschberger, L. L., Junior, C. & Stipanuk, M. H. Extrahepatic tissues compensate for loss of hepatic taurine synthesis in mice with liver-specific knockout of cysteine dioxygenase. Am. J. Physiol. Endocrinol. Metab. 302, E1292\u2013E1299 (2012).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"9018_CR25","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.yjmcc.2008.03.001","volume":"44","author":"T Ito","year":"2008","unstructured":"Ito, T. et al. Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J. Mol. Cell. Cardiol. 44, 927\u2013937 (2008).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"9018_CR26","doi-asserted-by":"publisher","first-page":"11507","DOI":"10.1096\/fj.201900914RR","volume":"33","author":"MN Preising","year":"2019","unstructured":"Preising, M. N. et al. Biallelic mutation of human SLC6A6 encoding the taurine transporter TAUT is linked to early retinal degeneration. FASEB J. 33, 11507\u201311527 (2019).","journal-title":"FASEB J."},{"key":"9018_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn9257","volume":"380","author":"P Singh","year":"2023","unstructured":"Singh, P. et al. Taurine deficiency as a driver of aging. Science 380, eabn9257 (2023).","journal-title":"Science"},{"key":"9018_CR28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nature09171","volume":"466","author":"T Ito","year":"2010","unstructured":"Ito, T. et al. Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature 466, 765\u2013768 (2010).","journal-title":"Nature"},{"key":"9018_CR29","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nm.2187","volume":"16","author":"MG Kharas","year":"2010","unstructured":"Kharas, M. G. et al. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nat. Med. 16, 903\u2013908 (2010).","journal-title":"Nat. Med."},{"key":"9018_CR30","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100293","volume":"38","author":"A Dey","year":"2019","unstructured":"Dey, A. et al. BRD4 directs hematopoietic stem cell development and modulates macrophage inflammatory responses. EMBO J. 38, e100293 (2019).","journal-title":"EMBO J."},{"key":"9018_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0092-8674(93)80065-M","volume":"75","author":"DJ Veis","year":"1993","unstructured":"Veis, D. J., Sorenson, C. M., Shutter, J. R. & Korsmeyer, S. J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229\u2013240 (1993).","journal-title":"Cell"},{"key":"9018_CR32","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","volume":"10","author":"S Pei","year":"2020","unstructured":"Pei, S. et al. Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia. Cancer Discov. 10, 536\u2013551 (2020).","journal-title":"Cancer Discov."},{"key":"9018_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41586-024-08137-x","volume":"636","author":"J Sango","year":"2024","unstructured":"Sango, J. et al. RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax. Nature 636, 241\u2013250 (2024).","journal-title":"Nature"},{"key":"9018_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature22993","volume":"547","author":"LI Shlush","year":"2017","unstructured":"Shlush, L. I. et al. Tracing the origins of relapse in acute myeloid leukaemia to stem cells. Nature 547, 104\u2013108 (2017).","journal-title":"Nature"},{"key":"9018_CR35","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S0022-3565(25)32850-8","volume":"219","author":"GG Yarbrough","year":"1981","unstructured":"Yarbrough, G. G., Singh, D. K. & Taylor, D. A. Neuropharmacological characterization of a taurine antagonist. J. Pharmacol. Exp. Ther. 219, 604\u2013613 (1981).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"9018_CR36","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1093\/jn\/112.12.2293","volume":"112","author":"RJ Huxtable","year":"1982","unstructured":"Huxtable, R. J. Guanidinoethane sulfonate and the disposition of dietary taurine in the rat. J. Nutr. 112, 2293\u20132300 (1982).","journal-title":"J. Nutr."},{"key":"9018_CR37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41586-024-07801-6","volume":"633","author":"W Wei","year":"2024","unstructured":"Wei, W. et al. PTER is a N-acetyltaurine hydrolase that regulates feeding and obesity. Nature 633, 182\u2013188 (2024).","journal-title":"Nature"},{"key":"9018_CR38","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1158\/0008-5472.CAN-10-4158","volume":"71","author":"JL Yecies","year":"2011","unstructured":"Yecies, J. L. & Manning, B. D. Transcriptional control of cellular metabolism by mTOR signaling. Cancer Res. 71, 2815\u20132820 (2011).","journal-title":"Cancer Res."},{"key":"9018_CR39","doi-asserted-by":"publisher","first-page":"e43418","DOI":"10.1371\/journal.pone.0043418","volume":"7","author":"YJ Choi","year":"2012","unstructured":"Choi, Y. J. et al. Inhibitory effect of mTOR activator MHY1485 on autophagy: suppression of lysosomal fusion. PLoS ONE 7, e43418 (2012).","journal-title":"PLoS ONE"},{"key":"9018_CR40","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1126\/science.1157535","volume":"320","author":"Y Sancak","year":"2008","unstructured":"Sancak, Y. et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496\u20131501 (2008).","journal-title":"Science"},{"key":"9018_CR41","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature25023","volume":"552","author":"H Yang","year":"2017","unstructured":"Yang, H. et al. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40. Nature 552, 368\u2013373 (2017).","journal-title":"Nature"},{"key":"9018_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"},{"key":"9018_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/science.aai8478","volume":"355","author":"AS Venteicher","year":"2017","unstructured":"Venteicher, A. S. et al. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science 355, eaai8478 (2017).","journal-title":"Science"},{"key":"9018_CR44","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","volume":"174","author":"E Azizi","year":"2018","unstructured":"Azizi, E. et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 174, 1293\u20131308 (2018).","journal-title":"Cell"},{"key":"9018_CR45","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s43018-020-00121-4","volume":"1","author":"NG Steele","year":"2020","unstructured":"Steele, N. G. et al. Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer. Nat. Cancer 1, 1097\u20131112 (2020).","journal-title":"Nat. Cancer"},{"key":"9018_CR46","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","volume":"24","author":"D Lambrechts","year":"2018","unstructured":"Lambrechts, D. et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat. Med. 24, 1277\u20131289 (2018).","journal-title":"Nat. Med."},{"key":"9018_CR47","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada, E. et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 9, 1102\u20131123 (2019).","journal-title":"Cancer Discov."},{"key":"9018_CR48","doi-asserted-by":"publisher","first-page":"5912","DOI":"10.1158\/1078-0432.CCR-20-3925","volume":"27","author":"JJ Lee","year":"2021","unstructured":"Lee, J. J. et al. Elucidation of tumor-stromal heterogeneity and the ligand-receptor interactome by single-cell transcriptomics in real-world pancreatic cancer biopsies. Clin. Cancer Res. 27, 5912\u20135921 (2021).","journal-title":"Clin. Cancer Res."},{"key":"9018_CR49","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1182\/blood-2011-04-348151","volume":"119","author":"BJ Frisch","year":"2012","unstructured":"Frisch, B. J. et al. Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. Blood 119, 540\u2013550 (2012).","journal-title":"Blood"},{"key":"9018_CR50","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.stem.2014.06.020","volume":"15","author":"M Hanoun","year":"2014","unstructured":"Hanoun, M. et al. Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. Cell Stem Cell 15, 365\u2013375 (2014).","journal-title":"Cell Stem Cell"},{"key":"9018_CR51","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2017.08.001","volume":"32","author":"D Passaro","year":"2017","unstructured":"Passaro, D. et al. Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia. Cancer Cell 32, 324\u2013341 (2017).","journal-title":"Cancer Cell"},{"key":"9018_CR52","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1182\/blood-2012-03-380147","volume":"120","author":"R Hehlmann","year":"2012","unstructured":"Hehlmann, R. How I treat CML blast crisis. Blood 120, 737\u2013747 (2012).","journal-title":"Blood"},{"key":"9018_CR53","doi-asserted-by":"publisher","first-page":"11008","DOI":"10.1073\/pnas.0704271104","volume":"104","author":"N Hosen","year":"2007","unstructured":"Hosen, N. et al. CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia. Proc. Natl Acad. Sci. USA 104, 11008\u201311013 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9018_CR54","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","volume":"138","author":"R Majeti","year":"2009","unstructured":"Majeti, R. et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 138, 286\u2013299 (2009).","journal-title":"Cell"},{"key":"9018_CR55","doi-asserted-by":"publisher","first-page":"8939","DOI":"10.1158\/0008-5472.CAN-04-0981","volume":"64","author":"T Mihailovic","year":"2004","unstructured":"Mihailovic, T. et al. Protein kinase D2 mediates activation of nuclear factor \u03baB by Bcr-Abl in Bcr-Abl+ human myeloid leukemia cells. Cancer Res. 64, 8939\u20138944 (2004).","journal-title":"Cancer Res."},{"key":"9018_CR56","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.tins.2016.07.002","volume":"39","author":"CE Finch","year":"2016","unstructured":"Finch, C. E. & Shams, S. Apolipoprotein E and sex bias in cerebrovascular aging of men and mice. Trends Neurosci. 39, 625\u2013637 (2016).","journal-title":"Trends Neurosci."},{"key":"9018_CR57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cell.2016.02.035","volume":"165","author":"L Chantranupong","year":"2016","unstructured":"Chantranupong, L. et al. The CASTOR proteins are arginine sensors for the mTORC1 pathway. Cell 165, 153\u2013164 (2016).","journal-title":"Cell"},{"key":"9018_CR58","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/science.aab2674","volume":"351","author":"RL Wolfson","year":"2016","unstructured":"Wolfson, R. L. et al. Sestrin2 is a leucine sensor for the mTORC1 pathway. Science 351, 43\u201348 (2016).","journal-title":"Science"},{"key":"9018_CR59","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/s43018-024-00811-3","volume":"5","author":"CD DiNardo","year":"2024","unstructured":"DiNardo, C. D. et al. Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b\/2 clinical trial and correlative analyses. Nat. Cancer 5, 1515\u20131533 (2024).","journal-title":"Nat. Cancer"},{"key":"9018_CR60","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1182\/blood.2024024837","volume":"145","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed or refractory acute myeloid leukemia. Blood 145, 486\u2013496 (2025).","journal-title":"Blood"},{"key":"9018_CR61","doi-asserted-by":"publisher","unstructured":"Kaszuba, C. M. et al. Identifying bone marrow microenvironmental populations in myelodysplastic syndrome and acute myeloid leukemia. J. Vis. Exp. https:\/\/doi.org\/10.3791\/66093 (2023).","DOI":"10.3791\/66093"},{"key":"9018_CR62","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","volume":"17","author":"R Browaeys","year":"2020","unstructured":"Browaeys, R., Saelens, W. & Saeys, Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat. Methods 17, 159\u2013162 (2020).","journal-title":"Nat. Methods"},{"key":"9018_CR63","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/neu.10337","volume":"59","author":"H Fujisawa","year":"2004","unstructured":"Fujisawa, H. Discovery of semaphorin receptors, neuropilin and plexin, and their functions in neural development. J. Neurobiol 59, 24\u201333 (2004).","journal-title":"J. Neurobiol"},{"key":"9018_CR64","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10545-014-9755-y","volume":"38","author":"A Jurecka","year":"2015","unstructured":"Jurecka, A., Zikanova, M., Kmoch, S. & Tylki-Szyma\u0144ska, A. Adenylosuccinate lyase deficiency. J. Inherit. Metab. Dis. 38, 231\u2013242 (2015).","journal-title":"J. Inherit. Metab. Dis."},{"key":"9018_CR65","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1523\/JNEUROSCI.5324-09.2010","volume":"30","author":"NA Sowa","year":"2010","unstructured":"Sowa, N. A., Taylor-Blake, B. & Zylka, M. J. Ecto-5\u2032-nucleotidase (CD73) inhibits nociception by hydrolyzing AMP to adenosine in nociceptive circuits. J. Neurosci. 30, 2235\u20132244 (2010).","journal-title":"J. Neurosci."},{"key":"9018_CR66","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.45572","volume":"8","author":"YP Kang","year":"2019","unstructured":"Kang, Y. P. et al. Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer. eLife 8, e45572 (2019).","journal-title":"eLife"},{"key":"9018_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb3713","volume":"6","author":"E Mahootchi","year":"2020","unstructured":"Mahootchi, E. et al. GADL1 is a multifunctional decarboxylase with tissue-specific roles in \u03b2-alanine and carnosine production. Sci. Adv. 6, eabb3713 (2020).","journal-title":"Sci. Adv."},{"key":"9018_CR68","doi-asserted-by":"publisher","first-page":"6521","DOI":"10.1074\/jbc.M209764200","volume":"278","author":"M Teufel","year":"2003","unstructured":"Teufel, M. et al. Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. J. Biol. Chem. 278, 6521\u20136531 (2003).","journal-title":"J. Biol. Chem."},{"key":"9018_CR69","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/jid.2011.29","volume":"131","author":"M Amyere","year":"2011","unstructured":"Amyere, M. et al. KITLG mutations cause familial progressive hyper- and hypopigmentation. J. Invest. Dermatol. 131, 1234\u20131239 (2011).","journal-title":"J. Invest. Dermatol."},{"key":"9018_CR70","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.4049\/jimmunol.172.7.3994","volume":"172","author":"A Fuchs","year":"2004","unstructured":"Fuchs, A., Cella, M., Giurisato, E., Shaw, A. S. & Colonna, M. Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155). J. Immunol. 172, 3994\u20133998 (2004).","journal-title":"J. Immunol."},{"key":"9018_CR71","doi-asserted-by":"publisher","first-page":"33481","DOI":"10.1074\/jbc.M114.593129","volume":"289","author":"H L\u00e4ubli","year":"2014","unstructured":"L\u00e4ubli, H. et al. Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs. J. Biol. Chem. 289, 33481\u201333491 (2014).","journal-title":"J. Biol. Chem."},{"key":"9018_CR72","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou, T. C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 70, 440\u2013446 (2010).","journal-title":"Cancer Res."},{"key":"9018_CR73","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731\u2013740 (2016).","journal-title":"Nat. Methods"},{"key":"9018_CR74","doi-asserted-by":"publisher","first-page":"9818","DOI":"10.1021\/ac1021166","volume":"82","author":"E Melamud","year":"2010","unstructured":"Melamud, E., Vastag, L. & Rabinowitz, J. D. Metabolomic analysis and visualization engine for LC-MS data. Anal. Chem. 82, 9818\u20139826 (2010).","journal-title":"Anal. Chem."},{"key":"9018_CR75","doi-asserted-by":"publisher","first-page":"D463","DOI":"10.1093\/nar\/gkv1042","volume":"44","author":"M Sud","year":"2016","unstructured":"Sud, M. et al. Metabolomics Workbench: an international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools. Nucleic Acids Res. 44, D463\u2013D470 (2016).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09018-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09018-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09018-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:28:45Z","timestamp":1757172525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09018-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":75,"journal-issue":{"issue":"8075","published-print":{"date-parts":[[2025,8,7]]}},"alternative-id":["9018"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-09018-7","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"11 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}